Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Mise à jour : Il y a 4 ans
Référence : NCT02400346

Femme et Homme

Extrait

The purpose of this study is to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in an elderly population with major depressive disorder and an inadequate response to antidepressant treatment


Critère d'inclusion

  • major depression disorder


Liens